These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28091215)

  • 1. Proton pump inhibitors could inhibit calcium absorption and weaken women's bones.
    Nurs Stand; 2012 Feb; 26(26):15. PubMed ID: 28091215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region.
    Reyes C; Formiga F; Coderch M; Hoyo J; Ferriz G; Casanovas J; Monteserín R; Brotons C; Rojas M; Moral I
    Bone; 2013 Feb; 52(2):557-61. PubMed ID: 23023097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hip fracture risk and use of proton-pump inhibitors.
    Nurs Older People; 2012 Apr; 24(4):13. PubMed ID: 27744777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the services provided by the women's health nurses in a Sydney Area Health Service.
    Barclay LM; Sebastian E; Mills AE; Jones LK; Schmied VA
    Aust Fam Physician; 1993 Nov; 22(11):2016-9, 2022-3. PubMed ID: 8304857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term proton pump inhibitor therapy and risk of hip fracture.
    Yang YX; Lewis JD; Epstein S; Metz DC
    JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].
    Maléth J; Hegyi P
    Orv Hetil; 2013 Jun; 154(26):1005-9. PubMed ID: 23800385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
    Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E
    Osteoporos Int; 2017 May; 28(5):1587-1595. PubMed ID: 28083667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.
    Moayyedi P; Cranney A
    Am J Gastroenterol; 2008 Oct; 103(10):2428-31. PubMed ID: 18855852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.
    Abrahamsen B; Vestergaard P
    Bone; 2013 Nov; 57(1):269-71. PubMed ID: 23973557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset.
    Bolland MJ; Grey A; Gamble GD; Reid IR
    PLoS One; 2015; 10(10):e0139975. PubMed ID: 26440516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors.
    Egan LJ; Murray JA
    Dig Dis; 2000; 18(2):58-63. PubMed ID: 11060468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's issues of migraine in tertiary care.
    Kelman L
    Headache; 2004 Jan; 44(1):2-7. PubMed ID: 14979877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
    Kaye JA; Jick H
    Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and impact of self-reported hip fracture in elderly community-dwelling women: the Women's Health and Aging Study.
    Hochberg MC; Williamson J; Skinner EA; Guralnik J; Kasper JD; Fried LP
    Osteoporos Int; 1998; 8(4):385-9. PubMed ID: 10024910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.